Vita means life. It's also our platform for sharing the stories of biotech's promise to patients and public health.
CSL consists of CSL Behring, CSL Seqirus and CSL Vifor. Learn more by visiting each section.
Biotechnology leader CSL Behring offers the broadest range of quality plasma-derived and recombinant therapies in our industry.
Derived from the expression 'securing health for all of us', CSL Seqirus is one of the world's largest influenza vaccine providers.
R&D focuses its expertise on four strategic platforms: plasma protein technology; recombinant technology; cell and gene therapy; and vaccines technology.
One of our core values at CSL is Innovation. We support collaborative innovation through the endowment of awards and grants to researchers around the world.
As part of our broader sustainability strategy to build a more sustainable future, we've committed to a 40% reduction in absolute Scope 1 and 2 emissions by 2030.
Along with our sustainability strategy, CSL’s community contribution framework helps deliver on our Values and support execution of our 2030 strategy.
At CSL, Inclusion and Belonging is at the core of our mission and who we are. It fuels our innovation day in and day out.
Whether you are early in your college education or recently completed your degree, it's never too soon to consider CSL for your Promising Future!
The National Organization for Rare Disorders (NORD) recently launched new informational resources on genetic testing, which c…
SimplyNano 2, an educational experiment kit for high school students, wins an award in Switzerland. CSL Vifor is among the ma…
The University of Pennsylvania’s Dr. Jim Wilson turned his love of cycling into an annual event that has channeled $17 millio…
Forster, a CSL Centenary Fellow is investigating the microbiome to find better treatments for patients who have inflammatory …
Wearables like smartwatches can capture a lot of health-related information. Researchers plan to assess the value of tracking…
Answering CSL.com’s survey, the leaders of nonprofit patient organizations said they are looking forward to a productive year…
What’s it like to work in the field? Heintz explains why it’s his favorite part of the job.
Survey sponsored by CSL found gaps in Australians’ understanding of iron deficiency, which is the world’s most common nutriti…
A Duke University expert recommends primary immunodeficiency patients take steps to protect themselves this holiday season. R…
Americas
Asia Pacific
Middle East
Europe
